Human medicines European public assessment report (EPAR): Clopidogrel Apotex (previously Clopidogrel Mylan Pharma), clopidogrel, Peripheral Vascular Diseases,Stroke,Myocardial Infarction, Date of authorisation: 16/10/2009, Revision: 18, Status: Authorised